Vimarsana
Biggest News Aggregation in the World

Page 5 - Acceleration Consortium News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acceleration Consortium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acceleration Consortium Today - Breaking & Trending Today

University of Toronto, Université de Montréal get combined $325 million as part of $1.4 billion federal investment into university innovation - Vimarsana News

University of Toronto, Université de Montréal get combined $325 million as part of $1.4 billion federal investment into university innovation

The University of Toronto and Université de Montréal have received a combined $325 million from the federal government for AI research initiatives.

'Self-driving' AI lab awarded $200M grant to pursue new drugs, materials - Vimarsana News

'Self-driving' AI lab awarded $200M grant to pursue new drugs, materials

The Acceleration Consortium designs new materials with AI and synthesizes them in-house with autonomous robots — a process that speeds up scientific discovery by decades, it says.

Alphafold AI and Robotic Science Lab Identified a New Liver Cancer Treatment - Vimarsana News

Alphafold AI and Robotic Science Lab Identified a New Liver Cancer Treatment

AlphaFold accelerates artificial intelligence powered drug discovery: efficient discovery of a novel CDK20 small molecule inhibitor”) has applied AlphaFold to

AlphaFold and AI Accelerate Design of New Liver Cancer Drug - Vimarsana News

AlphaFold and AI Accelerate Design of New Liver Cancer Drug

A new study has successfully used AlphaFold, an artificial intelligence (AI)-powered protein structure database, to accelerate the design and synthesis of a drug to treat the most common type of primary liver cancer.

Researchers use AI-powered database to design potential cancer drug in 30 days - Vimarsana News

Researchers use AI-powered database to design potential cancer drug in 30 days

In less than a month, researchers have used AlphaFold, an artificial intelligence (AI)-powered protein structure database, to design and synthesize a potential drug to treat hepatocellular carcinoma (HCC), the most common type of primary liver cancer.